早期检测肺高血压的方法
Lukas Ley1, Friedrich Grimminger, Manuel Richter
1Justus-Liebig-University Gießen, Campus Kerckhoff, Bad Nauheim; Medical Clinic IV, Gießen; Medical Clinic II, Gießen; Semmelweis University, Department of Medicine, 20099 Hamburg.
Deutsches Arzteblatt international
|October 26, 2023
概括
肺高血压 (PH) 影响全球人口的高达1%,往往是延迟诊断. 早期发现特定类型的肺动脉高血压 (PAH) 和慢性血栓栓塞性肺高血压 (CTEPH) 对于有效治疗至关重要.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 内部医学 内部医学
背景情况:
- 肺高血压 (PH) 影响世界人口的高达1%,诊断的延迟很大,平均超过一年.
- 患者在接受PH诊断之前经常咨询多名医生,突出诊断挑战.
研究的目的:
- 审查目前对肺高血压 (PH) 的理解和诊断策略.
- 强调早期检测特定PH亚型的重要性,并提供可用的治疗方法.
主要方法:
- 对肺高血压进行了选择性的文献搜索.
- 该审查综合了有关PH的原因,症状,诊断标准和转诊途径的信息.
主要成果:
- 左心脏病和肺部疾病是PH的最常见原因.
- 劳动性呼吸障碍是主要症状,随着疾病的进展;右心力衰竭症状在晚期出现.
- 肺动脉高血压 (PAH) 和慢性血栓栓塞性肺高血压 (CTEPH) 需要早期诊断,因为现有的特定治疗方法.
结论:
- 临床怀疑PH是由非特异性症状,心电图变化和升高的 (NT-pro-) BNP引起的.
- 心声图,心肺应力测试和排除左心肺疾病是关键的诊断步骤.
- 正常的 (NT-pro-) BNP和心电图使PH不太可能发生,强调需要明智地选择患者进行专家转诊.
相关概念视频
Pulmonary Hypertension: Classification and Pathogenesis
194
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
194
Mitral Stenosis II: Clinical features and Diagnostic Tests
22
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
22
Pulmonary Embolism I: Introduction
7
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
7
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
177
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
177
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
164
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
164
Radiological Investigation III: Pulmonary Angiogram and PET Scan
97
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
97


